Aurikos endobiogenika, MB Finance - revenue, profit
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 0 |
| - |
| 0 |
| 0 |
| - |
| - |
| - |
| 0 |
| 0 |
| 0 |
| 0 |
| 2024 |
|---|
| 5,120 |
| - |
| 3,779 |
| 3,779 |
| - |
| 76.95 |
| 73.81 |
| 3,788 |
| 0 |
| 0 |
| 3,788 |
| 2025 |
|---|
| 13,590 |
| - |
| 7,904 |
| 7,430 |
| - |
| 78.64 |
| 54.67 |
| 11,219 |
| 474 |
| 0 |
| 11,693 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 13,590 |
| - |
| 7,904 |
| 7,430 |
| - |
| 78.64 |
| 54.67 |
| 11,219 |
| 474 |
| 0 |
| 11,693 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
13,590 €165 % *
Sales per employee (€)
-Profit before tax (€)
7,904 €109 % *
Net Profit (€)
7,430 €97 % *
Profit per employee (€)
-Total profitability (%)
78.64 %2.20 % *
Net profitability (%)
54.67 %-25.93 % *
Equity (€)
11,219 €196 % *
Amounts Payable And Liabilities (€)
474 €- *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
11,693 €209 % *
